Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study

Patrick Linsel-Nitschke, Anika Götz, Jeanette Erdmann et al. · 2008

Read Lifelong Reduction of LDL-Cholesterol Related to a Common Variant in the LDL-Receptor Gene Decreases the Risk of Coronary Artery Disease—A Mendelian Randomisation Study by Patrick Linsel-Nitschke, Anika Götz, Jeanette Erdmann et al. (2008) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0002986.txt.

Description

Patrick Linsel-Nitschke, Anika Götz, Jeanette Erdmann and co-authors used a common LDL receptor variant to test lifelong cholesterol effects in 2008. Rare faults in the LDLR gene cause familial high cholesterol and raise coronary disease risk. What milder common variation does over a lifetime was less known.

Their Mendelian randomisation design treats inherited variants as a natural lifelong trial. The title reports that lifelong lower LDL cholesterol from this variant decreases coronary artery disease risk. Published in PLOS ONE, the logic strengthens the case that early, lasting cholesterol lowering protects the heart. The article appeared in PLOS ONE, an open access journal anyone can read free online.

Catalog record

CREATORPatrick Linsel-Nitschke, Anika Götz, Jeanette Erdmann et al.
YEAR2008
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0002986

Browse the full library · About the Tower of Babel